Dehydrated Human Amnion/Chorion Membrane to Treat Venous Leg Ulcers: A Cost-Effectiveness Analysis
Summary: This analysis evaluated the economic value of dehydrated human amnion/chorion membrane (dHACM) as an adjunct therapy for venous leg ulcers. dHACM achieved higher healing rates compared to standard care, leading to reduced overall treatment costs through faster closure, fewer dressing changes, and lower complication rates. The study supports its cost-effective role in managing chronic venous ulcers.
Key Highlights:
- Higher complete healing rates with dHACM
- Reduced total cost of care despite higher upfront product cost
- Fewer clinic visits and complications
- Strong value proposition for refractory venous leg ulcers
Keywords: dHACM venous ulcer, amniotic membrane cost effectiveness, venous leg ulcer treatment